PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with […]
» Read moreHome »
nohealthproblemsnews.com
Home »
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with […]
PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years